| Search ongoing for city execs
Search ongoing for city execs Long and extensive process allows for a larger candidate pool and nets better results, officials say. By Jason Wells CITY HALL — With a week left before the new year, Glendale is poised to move into 2008 with four vacant executive positions — an unprecedented amount, with top spots at the city's utility, fire, finance and library departments up for grabs.While all vacancies are in varied stages of recruitment, they represent a major turnaround among the city's 14 non-elected executive managers. .
Reds trade Hamilton to Rangers for pitching
The Cincinnati Reds agreed Friday to trade outfielder Josh Hamilton to the Texas Rangers for pitcher Edinson Volquez and a minor league pitcher.
The 26-year-old Hamilton batted .292 this year in his first major league season with 19 homers and 47 RBIs in 298 at-bats. His season was interrupted by an inflamed digestive track and a sprained wrist, but he still received 151,000 write-in votes for the All-Star game, the top total in the NL.
Taken by Tampa Bay with the first pick of the 1999 amateur draft, Hamilton didn't make it above Double-A with the Devil Rays, his career slowed by alcohol and drug addiction.
.
Walk to Wellness at Pleasanton park
Pleasanton-based pedometer and stopwatch manufacturer Accusplit, Inc. sponsors the first World Walk to Wellness from 11 a.m. to 1 p.m. today. The event is open to all ages and includes a self-guided 5,000-step walk (2.15 miles) around Pleasantons Sports and Community Park. The event is free at 5800 Parkside Drive, Pleasanton. Visit http://www.walking10000.org. Alta Bates Summit Medical Center The Markstein Cancer Education and Prevention Center presents a free discussion for those touched by cancer, featuring support group leader and therapist Connie Holmes, from 6:15-7:30 p.m. Jan. 9. Registration is recommended. At the Summit Campus, Peralta Pavilion, 430 30th St., Room 2810, Oakland. Call 510-869-8833. The weight-loss surgery support group New beginnings will be having meetings for people who have had or are considering weight-loss surgery.
Merck/Schering-Plough Pharmaceuticals Provides Results of the ENHANCE Trial
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.--(BUSINESS WIRE)--Merck/Schering-Plough Pharmaceuticals announced today the primary endpoint and other results of the ENHANCE (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia) trial. Merck/Schering-Plough has submitted an abstract on the ENHANCE trial for presentation at the American College of Cardiology meeting, which will be held in March 2008, and is awaiting notification of acceptance from the College. .
|
